brecht ingelbeen
@ingelbeen.bsky.social
660 followers 460 following 43 posts
infectious disease epidemiologist into antimicrobial resistance and population based studies. also a bit of urban cycling #EpiSky #IDSky
Posts Media Videos Starter Packs
Reposted by brecht ingelbeen
ourworldindata.org
Renewables have taken the lead in Dutch electricity production
The image presents a line graph illustrating the share of electricity generated from fossil fuels and renewables in the Netherlands from 1985 to 2024. 

The horizontal axis marks the years, starting at 1985 on the left and progressing to 2024 on the right. The vertical axis indicates the percentage of electricity generation, ranging from 0% to 100%. 

A brown line represents fossil fuels, which shows a gradual decline over the years, starting near 90% in 1985 and dropping sharply after 2015, approaching close to 40% by 2024. In contrast, a blue line illustrates renewables, showing a slow increase from nearly 0% in 1985 to a significant rise, crossing the fossil fuel line in 2024 to surpass it. 

The title notes the historic shift in Dutch electricity generation, indicating that for the first time, most electricity now comes from renewable sources. 

Data source: Ember (2025), Energy Institute (2024). The graph is licensed under CC BY.
ingelbeen.bsky.social
Open position for an ID modeler @itmantwerp.bsky.social on community-level + healthcare transmission of resistant #AMR bacteria in LRS, working with Clinical Research Unit Nanoro, @esthervk.bsky.social, @bugwonk.bsky.social, KEMRI-wellcome Kilifi, myself,... #IDSky #EpiSky
www.itg.be/en/jobs-and-...
Epidemiologist
Epidemiologist for modelling AMR transmission in LMICMore than 500 staff members at the Institute of Tropical Medicine (ITM) contribute e...
www.itg.be
ingelbeen.bsky.social
Thank you for sharing this. I don't get what @escmid.bsky.social hopes to obtain by restricting access after 6 months, or making it impossible to save posters
Reposted by brecht ingelbeen
stevenvangucht.bsky.social
Belgian waste water tells the story: Alpha. Delta. Omicron. Then viral loads dropped 10×.

Not luck. Not just Omicron.
But population immunity — built by vaccines + infections. Vaccines helped to avoid millions of deaths in the process.

Graph: Raphael Janssens

🔗 www.linkedin.com/posts/vanguc...
ingelbeen.bsky.social
Great work at GLASS that @esthervk.bsky.social presented at #ESCMIDglobal, providing regional trends in AMR prevalence in bloodstream infections #AMR #IDSky
ingelbeen.bsky.social
GLASS report with 2022 AMU data is out #IDSky #AMR
iris.who.int/bitstream/ha...

It has per capita antibiotic use expressed in DDD per 1000 inhabitants per day, confirming DID is lower in most low-income than in most high-income countries

Would be great to link population-wide AMU to AMR prevalence
Reposted by brecht ingelbeen
nerdychristie.bsky.social
If you love strong, pour-over coffee, a team of physicists has a tip: Pour from as high as you can without causing the stream to break apart. That and more of the best in @science.org and science in this edition of #ScienceAdviser: www.science.org/content/arti... 🧪
ingelbeen.bsky.social
Vienna was marvelous and going from Copenhagen to ESCMID by day- and nightrain was a fantastic experience
ingelbeen.bsky.social
I am surprised not to have picked up any major new treatment, prevention, or public health intervention breakthrough. I might have missed them, maybe I was queuing in the wrong lane, but blame the #ESCMIDGlobal app for that
ingelbeen.bsky.social
8. A meeting organised by the ESCMID Study Group for Antimicrobial Stewardship actors involved in AMS in LMICs shared experiences. I retain that scaling of AMS beyond few tertiary care hospitals is nearly absent in LMIC, but still nowhere near in most HIC too. Let apart in primary care.
ingelbeen.bsky.social
7. Two sessions on AMR and vaccines demonstrated again the lack of (recent) studies measuring effectiveness of (new+existing) vaccines on reducing antimicrobial use and AMR. Willian Hausdorff suggested developing combination vaccines by clinical presentation could better convince policy makers
ingelbeen.bsky.social
6. Erika Vlieghe gave a talk on developing a sepsis national action plan in Belgium and had to start with a disclaimer on the complexity of healthcare decisionmaking, having to deal with 7 health ministers. Preventive and curative care are dealt with by different state levels.
ingelbeen.bsky.social
5. Sonephet Vantava demonstrated how in hospitals in Lao PDR, healthcare worker attitudes and PPS antibiotic use data from will be combined to inform #AMS addressing frequent antibiotic use before and after delivery. Knowledge influences attitudes differently by profession @icarsglobal.bsky.social
ingelbeen.bsky.social
Vilada Chansamouth then demonstrated how they used pathogen distribution and AMR prevalence data to develop guidelines in Lao PDR
ingelbeen.bsky.social
4. A session on AMR surveillance gave excellent examples of analyzing and using clin micro AMR surveillance data, largely all examples from SE Asia. Many LMIC still struggle analyzing the data they have. Would be great if @WHO copy-pastes more from these examples
ingelbeen.bsky.social
3. A session on biomarkers reviewed evidence on use of CRP to treat outpatient respi tract infections or fevers in low-resource settings. Large differences in effectiveness largely due to differences in antibiotic use prevalence. A cheap single malaria +semiquantitative CRP lateral flow test awaited
ingelbeen.bsky.social
(I need to post one at a time apparently - takes a bit of time)
ingelbeen.bsky.social
2. On relevant metrics to evaluate #AMS interventions: Days of Antibiotic Spectrum Coverage/DASC not only measures days of treatment but also at how wide the spectrum is of the antibiotic administered. Narrowing treatment is measured, and thus effectiveness in limiting selective pressure
ingelbeen.bsky.social
1. Plans to harmonise and merge global-PPS and the WHO PPS. Countries I work with often pick the WHO PPS but then struggle to analyze antimicrobial use in sufficient detail to inform AMS or to benchmark w/ others. Planned for the next year or so, but still unclear how data sharing will go #ESCMID
ingelbeen.bsky.social
for 4,5 days of #ESCMIDGlobal with permanently 20 sessions in parallel and some #IDSky skeeters posting about sessions I wasn't in, more than once I had the feeling I have when picking a lane in a supermarket. Some bits I learned, mostly relevant for #AMR control intervention implementation in LMIC:
ingelbeen.bsky.social
Couldn’t it also have been a lower prevalence of known covid19 risk factors (diabetes, hypertension, copd) in each age stratum?
Reposted by brecht ingelbeen
yanisvaroufakis.bsky.social
Day in day out, Israel is adding war crime to war crime, with the world looking for something 'new' to worry about. We are running the danger of becoming de-sensitised. Resistance now takes more than to condemn the genocide. We must also oppose the de-sensitisation of our souls!
Reposted by brecht ingelbeen
lancetmicrobe.bsky.social
New comment

The cost of blood cultures: a barrier to diagnosis in low-income and middle-income countries

www.thelancet.com/journals/lan...

#IDSky #ClinMicro #OpenAccess #OA
Reposted by brecht ingelbeen
jburnmurdoch.ft.com
NEW 🧵 Is human intelligence starting to decline?

Recent results from major international tests show that the average person’s capacity to process information, use reasoning and solve novel problems has been falling since around the mid 2010s

What should we make of this?

www.ft.com/content/a801...
Reposted by brecht ingelbeen
infectiousdz.bsky.social
Cholera in Angola:
As of 11 March 2025, a total of 6,651 cholera cases have been reported in Angola, with 240 death (Case Fatality Rate of 3.6%)

The outbreak creates a risk for spread
Despite no cholera in Namibia for over a decade, 1 case has been confirmed in Namibia, just south of Angola border